title: Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation.
abstract: All individuals with diabetes mellitus should be screened yearly with a spot urine albumin:creatinine ratio to identify those who are at increased risk for the development of complications of diabetes mellitus, including nephropathy, retinopathy, and cardiovascular disease. Once these high-risk individuals are appropriately identified, it is recommended that therapy with an angiotensin-converting enzyme (ACE) inhibitor be initiated. In addition, cardiovascular risk factors should be investigated, and when appropriate, therapeutic interventions should be initiated according to existing recommendations.
authors: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
authors: P H
authors: PH
authors: Bennett
authors: S
authors: S
authors: Haffner
authors: B L
authors: BL
authors: Kasiske
authors: W F
authors: WF
authors: Keane
authors: C E
authors: CE
authors: Mogensen
authors: H H
authors: HH
authors: Parving
authors: M W
authors: MW
authors: Steffes
authors: G E
authors: GE
authors: Striker
mesh_terms: D000419:Albuminuria / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D003663:Decision Trees; D048909:Diabetes Complications; D003928:Diabetic Nephropathies / Q000175:diagnosis; D005582:Foundations; D006801:Humans; D008403:Mass Screening; D009398:Nephrology; D012307:Risk Factors; D014481:United States